The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)

Keiichi Tsuchida1 Antonio Colombo2 Thierry Lefèvre3 Keith G. Oldroyd4 Victor Guetta5 Giulio Guagliumi6 Wolfgang von Scheidt7 Witold Ruzyllo8 Christian W. Hamm9 Marco Bressers10 Hans-Peter Stoll11 Kristel Wittebols11 Dennis J. Donohoe11 and Patrick W. Serruys1

首页> 外文期刊>European Heart Journal >The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)

【24h】

The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)

机译：西罗莫司洗脱支架经皮治疗多支冠状动脉病变分叉病变的临床结果：动脉血运重建治疗研究第二部分（ARTS II）的见解

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims Little is known about the impact of treating bifurcations on the overall outcome of multivessel coronary artery disease treated with stenting. This analysis was made to investigate the 1 year clinical outcome of the treatment of bifurcation lesions using sirolimus-eluting stents (SES) in patients with multivessel disease.

机译：目的关于用支架置入术治疗分叉对多支冠状动脉疾病总体结果的影响知之甚少。进行该分析以调查在多支血管疾病患者中使用西罗莫司洗脱支架（SES）治疗分叉病变的1年临床结果。

著录项

来源
《European Heart Journal 》 |2007年第4期| 433-442| 共10页
作者
Keiichi Tsuchida1 Antonio Colombo2 Thierry Lefèvre3 Keith G. Oldroyd4 Victor Guetta5 Giulio Guagliumi6 Wolfgang von Scheidt7 Witold Ruzyllo8 Christian W. Hamm9 Marco Bressers10 Hans-Peter Stoll11 Kristel Wittebols11 Dennis J. Donohoe11 and Patrick W. Serruys1;
展开▼
作者单位

Thoraxcenter Ba 583 Erasmus Medical Center Dr. Molewaterplein 40 3015 GD Rotterdam The Netherlands;

EMO Centro Cuore Columbus and San Raffaele Hospital Milan Italy;

Institut Cardiovasculaire Paris Sud Massy France;

Lanarkshire Acute Hospitals Glasgow UK;

Chaim Sheba Medical Center Tel Hashomer Israel;

Azienda Ospedaliera Ospedali Riunitit di Bergamo Bergamo Italy;

Klinikum Augsburg Augsburg Germany;

Institute of Cardiology Warsaw Warsaw Poland;

Kerckhoff Klinik Kardiologie Bad Nauheim Germany;

Cardialysis B.V. Rotterdam The Netherlands;

Cordis Corporation Miami Lakes FL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. [J] . Serruys PW, Onuma Y, Garg S, Journal of the American College of Cardiology . 2010 ,第11期

机译：西罗莫司洗脱支架的ARTS II（动脉血运重建疗法研究II）在多发性新生冠状动脉病变患者中的5年临床结果。
2. Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-Ⅱ) [J] . N Kukreja, P W Serruys, B De Bruyne, Heart . 2009 ,第13期

机译：西罗莫司洗脱支架，裸机支架或冠状动脉搭桥术治疗包括左近端前降支动脉近端在内的多支血管疾病：动脉血运重建疗法研究第二部分（ARTS-Ⅱ）
3. Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II). [J] . Khattab AA, Daemen J, Richardt G, The American Journal of Cardiology . 2008 ,第11期

机译：体重指数对接受西罗莫司洗脱支架进行多支血管重建术的患者一年临床结局的影响（摘自《动脉血运重建治疗研究》第二部分）。
4. The Long-Term Clinical Results of a Platelet Glycoprotein Ilb/IIIa Receptor Blocker (Abciximab: ReoPro~R)-Coated Stent in Patients with Coronary Artery Disease [C] . W. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：冠状动脉疾病患者的血小板糖蛋白ILB / IIIA受体阻滞剂（Abciximab：Reopro〜R）涂层支架的长期临床结果
5. Treatment Decision Making in Multivessel Coronary Artery Disease [D] . Nichols, Elizabeth L. 2018

机译：多支冠状动脉疾病的治疗决策
6. Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year—Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS) [O] . Vladimir Ganyukov, Nikita Kochergin, Aleksandr Shilov, 2020

机译：多支冠状动脉疾病的手术经皮或混合血运重建的随机临床试验：残存的心肌缺血和一年的临床结果—混合冠状动脉血运重建与支架或手术（HREVS）
7. Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II) [O] . Legrand, Victor, Garg, Scott, Serruys, Patrick, 2011

机译：年龄对多发性新生冠状动脉病变患者治疗冠状动脉血运重建的临床结果的影响：西罗莫司洗脱支架与冠状动脉搭桥术和裸金属支架的比较，来自多中心随机动脉血运重建治疗研究第一部分的见解（ ARTS-I）和第二部分（ARTS-II）

The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)

摘要

著录项

相似文献

相关主题

期刊订阅